The trademark application CIFIGRY was filed by Corcept Therapeutics Incorporated, a U.S. corporation (the "Applicant"). The application was published for oppositions on March 15, 2022, and it was registered by office on June 22, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations for the treatment of endocrine diseases and disorders
Pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders
Pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease
Pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders.